兔抗DRG1多克隆抗體

Background:

DRG1 (developmentally regulated GTP binding protein 1), also known as NEDD3 (neural precursor cell expressed developmentally down-regulated protein 3), is a 367 amino acid protein that localizes to the cytoplasm and belongs to the GTP1/OBG family. Expressed at high levels in heart, kidney and skeletal muscle and at lower levels in brain, liver, placenta, lung, colon and spleen, DRG1 binds to TAL1 and TAL2 and is thought to play a role in cell proliferation and differentiation, as well as in apoptosis, suggesting a role in tumor formation and metastasis. DRG1 is subject to polyubiquitination and sumoylation, the former of which induces proteolytic degradation. The gene encoding DRG1 maps to human chromosome 22, which houses over 500 genes and is the second smallest human chromosome. Mutations in several of the genes that map to chromosome 22 are involved in the development of Phelan-McDermid syndrome, Neurofibromatosis type 2, autism and schizophrenia.

Applications:

ELISA, WB, IHC

Name of antibody:

DRG1

Immunogen:

Fusion protein of human DRG1

Full name:

developmentally regulated GTP binding protein 1

Synonyms：

NEDD3

SwissProt:

Q9Y295

ELISA Recommended dilution:

2000-5000

IHC positive control:

Human thyroid cancer and human liver cancer

IHC Recommend dilution:

50-200

WB Predicted band size:

41 kDa

WB Positive control:

Human fetal liver and brain tissue, 293T and Hela cells

WB Recommended dilution:

500-2000